Osavi Sodium Butyrate 960mg for Gastrointestinal Microbiome Support and Gut Barrier Integrity
Osavi Sodium Butyrate delivers a highly stable source of butyric acid, a vital short-chain fatty acid (SCFA) acting as the primary colonocyte energy supply for the intestinal epithelium. This professional-grade formula is developed to reinforce gut barrier integrity, optimize mucosal lining health, and sustain a balanced gastrointestinal microbiome. Each commercial bottle provides 60 Capsules, allowing for highly versatile clinical dosing protocols: a standard 1-capsule serving supplies 480mg of sodium butyrate (yielding 384mg of active butyric acid), whereas an intensive 2-capsule daily serving provides a potent 960mg of sodium butyrate (yielding 768mg of pure butyric acid). This configuration aligns perfectly with either a 30-day intensive or a 60-day maintenance application, giving medical professionals and retailers predictable, high-utility options for client protocols.
Target Business Channels and Portfolio Expansion
This short-chain fatty acid formulation is perfectly suited for distribution through private medical practices, integrative gastroenterology clinics, specialized pharmacies, and premium health e-commerce portals. Adding this stable butyrate solution into your product portfolio addresses the growing business and clinical demand for advanced, science-based metabolic and gastrointestinal support supplements.
Manufacturer Standards and Quality Verification
Osavi is a recognized European manufacturer dedicated to clean-label purity, strict ingredient traceability, and thorough laboratory testing parameters. “Human Performance” is the official representative and authorized EU distributor of this manufacturer, ensuring direct supply and the highest level of wholesale quality control. Batch-specific Certificates of Analysis (CoA) are centralized and grouped by brand at the official certificates page (available for select premium compounds) or can be provided upon direct corporate request.
Composition and Active Ingredients
SODIUM BUTYRATE 960MG – Commercial Product / Food Supplement.
Commercial Packaging: 60 Capsules.
Manufacturer: Olivit Sp. z o.o., ul. Blacharska 11, 61-006 Poznan, Poland.
Brand & Research: Human Performance Pro LLC | Reg: 2026-001917076 | 30 N Gould St, Ste N, Sheridan, WY 82801, USA | +1 (646) 806-6690
Operations & Logistics: Human Performance UAB | Reg: 302572889 | VAT: LT100011352913 | Mindaugo g. 27, Vilnius, Lithuania. Logistics and fulfillment are managed via certified enterprise-grade 3PL warehousing to guarantee secure, compliant, and temperature-controlled distribution across the EU (b2b.humanperformance.pro).
Ingredients: Sodium butyrate, capsule shell (hydroxypropyl methyl cellulose), bulking agent (microcrystalline cellulose), anti-caking agents (magnesium salts of fatty acids, silicon dioxide).
| Active Ingredient / Specification | Per 1 Capsule | Per 2 Capsules (Daily Serving) |
|---|---|---|
| Sodium Butyrate | 480 mg | 960 mg |
| – of which Butyric Acid | 384 mg | 768 mg |
| Energy Value | 16 kJ / 4 kcal | 32 kJ / 8 kcal |
| Fat (of which saturated fatty acids) | 0.4 g (0.4 g) | 0.8 g (0.8 g) |
| Carbohydrates (of which sugars) | 0 g (0 g) | 0 g (0 g) |
| Fibre | 0.3 g | 0.6 g |
| Protein | 0 g | 0 g |
| Salt | 0.1 g | 0.2 g |
B2B Professional Notice & Legal Disclaimer
Strictly for Internal B2B and Professional Use Only. The scientific data, research summaries, and biological mechanisms (including references to short-chain fatty acids, gut barrier integrity, and colonocyte energy supply) presented on this page are provided solely for informational and educational purposes. This content is intended exclusively for corporate procurement managers, certified medical clinics, pharmacies, research institutions, and licensed healthcare practitioners.
These statements and product descriptions have not been evaluated by the European Food Safety Authority (EFSA) or the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any medical condition or disease. It is the sole statutory responsibility of the purchasing business entity, distributor, or healthcare professional to verify and ensure full compliance with national and local regulations before commercializing, presenting, or compounding these formulas for end-consumers.